GnRH Agonists and Antagonists in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
399-410
Author(s):
Murty V. Chengalvala, Jeffrey C. Pelletier and Gregory S. Kopf
Silence of the Genes: A Targeted Approach to the Suppression of Specific Genes in Human Disease Using Small Interfering RNA (siRNA)
Journal:
Current Genomics
Volume:
4
Page:
587-598
Author(s):
Jim Apostolopoulos
Microarrays and Mass Spectrometry - The Future of Proteomics
Journal:
Current Genomics
Volume:
4
Page:
605-613
Author(s):
K. S. Deshpande, H. C. Harsha and A. Pandey
Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
452-467
Author(s):
Lily Wu and Makoto Sato
Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2009-2023
Author(s):
Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner
Bradykinin Antagonists as Anti-Cancer Agents
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2036-2042
Author(s):
J. M. Stewart
Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer
Prodrugs in Genetic Chemoradiotherapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2131-2154
Author(s):
Adam V. Patterson, Mark P. Saunders and Olga Greco
The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target
Journal:
Current Drug Targets
Volume:
4
Page:
517-524
Author(s):
Anne-Sophie Belzacq and Catherine Brenner
Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Journal:
Current Drug Targets
Volume:
4
Page:
537-564
Author(s):
Nikolaus Seiler